EspañolLatest Products
Medical Screening of a Repatriated Afghan National Army Special Operations Command Prisoner of War$35.00- Severe Lower Body Swelling and Bacteremia Secondary to Shewanella algae Bacteremia During Basic Underwater Demolition SEAL Training$35.00
- United States Military Parachute Injuries: Part 2: Interventions Reducing Military Parachute Injuries in Training and Operations$35.00
- Applying Swiss Armed Forces Training Didactics and Methodology for Tactical Combat Casualty Care Training$35.00
Use of Atomized Intranasal Tranexamic Acid as an Adjunctive Therapy in Difficult-to-Treat Epistaxis
Sarkar D, Martinez J 19(2). 23 - 28 (Case Reports)
There is a growing body of literature on the safe, effective use of tranexamic acid (TXA) for hemostasis in a variety of clinical settings. We present a case series of three patients with difficult-to-treat epistaxis where standard treatment methods were not effective. Using atomized intranasal TXA (ATXA) as part of a stepwise treatment approach, we were able to achieve hemostasis and manage all three cases independently, and we did so without major complications in our emergency department (ED). Given recent literature showing the underuse of TXA in combat casualties, ATXA, if formulated and delivered properly, may be of benefit for epistaxis and other significant hemorrhage cases. Further work must be done to elucidate the mechanism of action, specific dose, delivery method, use indications, and safety profile of ATXA.
- Manufacturer: Breakaway Media, LLC
